Tiziana Life Sciences Ltd
TLSA2.455USD
+0.075+3.15%
시장 운영 시간 （ET）시세는 15분 지연됩니다
273.64M시가총액
--P/E TTM
자세한 내용은 Tiziana Life Sciences Ltd 회사
Tiziana Life Sciences Ltd. is a United Kingdom-based clinical-stage biotechnology company that is specialized in the developing transformative therapies for neurodegenerative and neuroinflammatory. The Company’s clinical pipeline includes drug assets for secondary progressive multiple sclerosis, Alzheimer’s, and ALS. Its lead immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer’s and other CNS indications. Its Anti IL-6R mAb (TZLS-501), a fully human mAb binds to both membrane-bound and soluble forms of IL-6R, an inflammatory cytokine driving chronic inflammation associated with autoimmune disease and cancer, reducing circulating levels of the IL-6 cytokine.
회사 정보
종목 코드 TLSA
회사 이름Tiziana Life Sciences Ltd
상장일Nov 20, 2018
CEOMr. Ivor Elrifi
직원 수- -
유형Ordinary Share
회계 연도 종료Nov 20
주소- -
도시- -
증권 거래소NASDAQ Capital Market Consolidated
국가- -
우편 번호- -
전화- -
웹사이트- -
종목 코드 TLSA
상장일Nov 20, 2018
CEOMr. Ivor Elrifi
회사 임원
이름
이름/직위
직위
주식 보유
변동
Mr. Willy Jules Simon
Mr. Willy Jules Simon
Non-Executive Independent Director
Non-Executive Independent Director
8.25K
--
Mr. John P. Brancaccio, CPA
Mr. John P. Brancaccio, CPA
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Gabriele Marco Antonio Cerrone
Mr. Gabriele Marco Antonio Cerrone
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Ivor Elrifi
Mr. Ivor Elrifi
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
--
--
Ms. Keeren Shah
Ms. Keeren Shah
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
--
--
Dr. William A. Clementi, Pharm.D.
Dr. William A. Clementi, Pharm.D.
Chief Development Officer
Chief Development Officer
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. Willy Jules Simon
Mr. Willy Jules Simon
Non-Executive Independent Director
Non-Executive Independent Director
8.25K
--
Mr. John P. Brancaccio, CPA
Mr. John P. Brancaccio, CPA
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Gabriele Marco Antonio Cerrone
Mr. Gabriele Marco Antonio Cerrone
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Ivor Elrifi
Mr. Ivor Elrifi
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
--
--
Ms. Keeren Shah
Ms. Keeren Shah
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
--
--
Dr. William A. Clementi, Pharm.D.
Dr. William A. Clementi, Pharm.D.
Chief Development Officer
Chief Development Officer
--
--
수익 분석
데이터 없음
데이터 없음
사업별
지역별
데이터 없음
주식 보유 통계
마지막 업데이트: Sat, Jun 14
마지막 업데이트: Sat, Jun 14
주주
주주 유형
주주
주주
비율
Cerrone (Gabriele M)
37.71%
Chernett (Jorey)
5.34%
Dauntless Investment Group, LLC
1.56%
Jane Street Capital, L.L.C.
0.15%
OMERS Administration Corporation
0.13%
Other
55.10%
주주
주주
비율
Cerrone (Gabriele M)
37.71%
Chernett (Jorey)
5.34%
Dauntless Investment Group, LLC
1.56%
Jane Street Capital, L.L.C.
0.15%
OMERS Administration Corporation
0.13%
Other
55.10%
주주 유형
주주
비율
Individual Investor
43.06%
Investment Advisor
2.04%
Research Firm
0.26%
Investment Advisor/Hedge Fund
0.25%
Pension Fund
0.13%
Hedge Fund
0.04%
Other
54.22%
기관 주식 보유
마지막 업데이트: Tue, Jul 1
마지막 업데이트: Tue, Jul 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q2
68
51.04M
45.79%
+9.50M
2025Q1
69
45.10M
40.46%
+3.34M
2024Q4
64
40.33M
36.45%
-5.07M
2024Q3
58
41.30M
37.43%
-3.04M
2024Q2
51
40.27M
36.45%
-4.04M
2024Q1
48
40.16M
36.35%
-4.27M
2023Q4
52
45.25M
44.24%
+1.19M
2023Q3
58
45.24M
44.24%
+1.10M
2023Q2
54
45.32M
44.32%
+1.19M
2023Q1
53
45.06M
44.06%
+868.09K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Cerrone (Gabriele M)
42.04M
37.71%
+2.70M
+6.85%
Mar 31, 2025
Chernett (Jorey)
5.95M
5.34%
+5.95M
--
Jun 11, 2025
Dauntless Investment Group, LLC
1.74M
1.56%
+1.74M
--
Mar 31, 2025
Jane Street Capital, L.L.C.
167.54K
0.15%
+151.86K
+968.24%
Mar 31, 2025
OMERS Administration Corporation
144.90K
0.13%
+144.90K
--
Mar 31, 2025
HSBC Global Asset Management (UK) Limited
105.36K
0.09%
--
--
Mar 31, 2025
Morgan Stanley & Co. LLC
92.57K
0.08%
+18.20K
+24.47%
Mar 31, 2025
Zhang Financial LLC
96.26K
0.09%
+3.07K
+3.30%
Mar 31, 2025
Kovitz Investment Group Partners, LLC
79.36K
0.07%
--
--
Mar 31, 2025
Geode Capital Management, L.L.C.
77.89K
0.07%
-167.84K
-68.30%
Mar 31, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Aug 2
마지막 업데이트: Sat, Aug 2
이름
비율
Fidelity Nasdaq Composite Index ETF
0%
Fidelity Nasdaq Composite Index ETF
비율0%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
Oct 20, 2021
Merger
2<1
Oct 20, 2021
Merger
2<1
Oct 20, 2021
Merger
2<1
Oct 20, 2021
Merger
2<1
Jul 16, 2020
Split
1>2.5
날짜
유형
비율
Oct 20, 2021
Merger
2<1
Oct 20, 2021
Merger
2<1
Oct 20, 2021
Merger
2<1
Oct 20, 2021
Merger
2<1
Jul 16, 2020
Split
1>2.5
